Latest Insider Transactions at Clover Health Investments, Corp. (CLOV)
This section provides a real-time view of insider transactions for Clover Health Investments, Corp. (CLOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CLOVER HEALTH INVESTMENTS, CORP. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CLOVER HEALTH INVESTMENTS, CORP. 's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 04
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
6,823
-0.21%
|
$13,646
$2.89 P/Share
|
Jul 31
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
29,513
-0.89%
|
$59,026
$2.89 P/Share
|
Jul 31
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
27,930
-1.64%
|
$55,860
$2.89 P/Share
|
Jul 31
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
25,081
-1.0%
|
$50,162
$2.89 P/Share
|
Jul 29
2025
|
Peter J. Kuipers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217,382
-3.42%
|
$434,764
$2.89 P/Share
|
Jul 23
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Open market or private sale
|
Indirect |
91,197
-6.1%
|
$273,591
$3.32 P/Share
|
Jul 22
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Open market or private sale
|
Indirect |
118,600
-7.35%
|
$355,800
$3.29 P/Share
|
Jul 07
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
2,012
-0.06%
|
$4,024
$2.85 P/Share
|
Jul 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,706
-0.26%
|
$17,412
$2.56 P/Share
|
Jul 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
19,789
-0.59%
|
$39,578
$2.58 P/Share
|
Jul 01
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,950
-2.84%
|
$617,900
$2.75 P/Share
|
Jun 30
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
85,596
-2.51%
|
$171,192
$2.79 P/Share
|
Jun 30
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
217,523
+5.99%
|
-
|
Jun 17
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
20,450
-0.64%
|
$40,900
$2.86 P/Share
|
Jun 15
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,404
-0.51%
|
$12,808
$2.89 P/Share
|
Jun 15
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,691
-0.27%
|
$17,382
$2.89 P/Share
|
Jun 14
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
98,411
-3.04%
|
$196,822
$2.89 P/Share
|
Jun 14
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
12,567
-0.39%
|
$25,134
$2.89 P/Share
|
May 19
2025
|
Peter J. Kuipers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
326,647
+4.89%
|
-
|
May 14
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,345
-0.42%
|
$16,035
$3.31 P/Share
|
May 08
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,535
-0.78%
|
$256,605
$3.75 P/Share
|
Apr 30
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
27,293
-2.11%
|
$81,879
$3.4 P/Share
|
Apr 30
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
25,080
-1.05%
|
$75,240
$3.4 P/Share
|
Apr 30
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
25,659
-0.79%
|
$76,977
$3.4 P/Share
|
Apr 30
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
26,593
-0.81%
|
$79,779
$3.4 P/Share
|
Apr 29
2025
|
Peter J. Kuipers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825,989
-12.06%
|
$2,477,967
$3.45 P/Share
|
Apr 18
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
38,261
-1.58%
|
$114,783
$3.6 P/Share
|
Apr 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
6,366
-0.19%
|
$19,098
$3.51 P/Share
|
Apr 01
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,950
-2.74%
|
$926,850
$3.59 P/Share
|
Mar 15
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,589
-0.35%
|
$13,767
$3.66 P/Share
|
Mar 15
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
6,354
-0.19%
|
$19,062
$3.66 P/Share
|
Mar 14
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
80,524
-2.41%
|
$241,572
$3.66 P/Share
|
Mar 14
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
9,188
-0.28%
|
$27,564
$3.66 P/Share
|
Mar 07
2025
|
Carladenise Armbrister Edwards Director |
SELL
Open market or private sale
|
Direct |
200,000
-42.26%
|
$600,000
$3.61 P/Share
|
Mar 06
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Open market or private sale
|
Direct |
75,000
-3.01%
|
$225,000
$3.68 P/Share
|
Mar 06
2025
|
Karen Soares General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
52,500
-3.88%
|
$157,500
$3.8 P/Share
|
Feb 14
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,345
-0.39%
|
$21,380
$4.46 P/Share
|
Feb 08
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,535
-0.75%
|
$342,140
$4.32 P/Share
|
Jan 31
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
24,470
-0.73%
|
$97,880
$4.39 P/Share
|
Jan 31
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
18,987
-0.76%
|
$75,948
$4.39 P/Share
|
Jan 31
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
21,578
-0.65%
|
$86,312
$4.39 P/Share
|
Jan 31
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
28,553
-2.06%
|
$114,212
$4.39 P/Share
|
Jan 18
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
38,560
-1.51%
|
$154,240
$4.08 P/Share
|
Jan 07
2025
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,670,965
-54.25%
|
$5,012,895
$3.6 P/Share
|
Jan 07
2025
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,670,965
+35.17%
|
-
|
Jan 07
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
17,142
-0.52%
|
$51,426
$3.6 P/Share
|
Jan 07
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,308
-0.31%
|
$12,924
$3.6 P/Share
|
Jan 06
2025
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+11.41%
|
-
|
Jan 06
2025
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+9.23%
|
-
|
Jan 06
2025
|
Thomas L Tran Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+37.72%
|
-
|